Citigroup started coverage on shares of R1 RCM ( NASDAQ:RCM – Free Report ) in a report released on Friday, Marketbeat reports. The brokerage issued a buy rating and a $20.00 price target on the healthcare provider's stock. Several other brokerages have also recently commented on RCM. Barclays boosted their price objective on shares of R1 RCM from $18.00 to $20.00 and gave the company an overweight rating in a research note on Thursday, August 3rd. Royal Bank of Canada increased their price objective on R1 RCM from $18.

https://www.dailypolitical.com/2023/09/23/r1-rcm-nasdaqrcm-receives-new-coverage-from-analysts-at-citigroup.html

#dailypolitical